LRRC55 Activators are a distinct class of chemical entities that specifically augment the activity of the LRRC55 protein, a leucine-rich repeat-containing protein that is integral to specific cellular functions. These activators engage in precise molecular interactions that result in the enhanced activity of LRRC55, facilitating its role within the biological context. For instance, certain small molecule agonists bind directly to LRRC55 or its associated factors, leading to conformational changes that boost the protein's functional state. Others may work allosterically, modifying the protein's structure in a way that increases its affinity for natural ligands or its interaction with other proteins within the same pathway. The specificity of these activators is critical, as they do not simply increase the expression levels of the LRRC55 gene but rather fine-tune the protein's activity by influencing its post-translational modifications or its interaction with other cellular components. This precise mechanism ensures that the activators enhance the natural role of LRRC55 without altering its intrinsic expression patterns or overarching regulatory mechanisms.
The biochemical activation mechanisms of LRRC55 Activators are rooted in their ability to modulate the protein's involvement in signaling cascades and cellular processes. Some activators may influence the phosphorylation state of LRRC55, which is a critical post-translational modification that can dictate the protein's activity and its ability to propagate cellular signals. Others might interact with secondary messenger systems, thereby indirectly impacting the protein's function by shifting the balance of intracellular signaling molecules in favor of pathways that activate LRRC55. The interaction of these chemicals with the intricate network of cellular signaling offers a targeted approach to enhance the protein's activity. Through these multifaceted and highly specific actions, LRRC55 Activators contribute to the protein's optimal functionality, ensuring that it can efficiently fulfill its role within the cellular milieu. These activators are thus pivotal in sustaining the delicate balance of LRRC55's involvement in its native cellular processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly increases intracellular cAMP, which can enhance LRRC55 activity by promoting a permissive state for its associated ion channels, potentially altering their conductivity and kinetics. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C which can lead to phosphorylation events that indirectly enhance LRRC55 functionality by modulating the membrane environment and associated channel activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentration, indirectly enhancing LRRC55 function by affecting the calcium-sensitive signaling pathways that regulate channel activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that enhances LRRC55 activity by mimicking the second messenger role of cAMP, thereby affecting the phosphorylation state of associated proteins and channels. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K8644 acts as a calcium channel agonist, indirectly enhancing LRRC55 by increasing the intracellular calcium, which can modulate the activity of calcium-sensitive proteins and pathways linked to LRRC55. | ||||||
1,2-Dioctanoyl-sn-glycerol | 60514-48-9 | sc-202397 sc-202397A | 10 mg 50 mg | $47.00 $254.00 | 2 | |
DOG is a diacylglycerol analog that can activate protein kinase C, potentially enhancing LRRC55 by modulating the phosphorylation state of proteins in associated signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that raises intracellular calcium levels, indirectly enhancing LRRC55 activity through the activation of calcium-dependent signaling mechanisms. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which leads to increased cAMP levels, indirectly enhancing LRRC55 function by influencing the cAMP-dependent pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can inhibit certain types of kinases, which may indirectly enhance LRRC55 activity by reducing inhibitory phosphorylation events within associated signaling pathways. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM is a cell-permeable calcium chelator that can indirectly enhance LRRC55 by modulating intracellular calcium levels and affecting calcium-dependent processes. | ||||||